L'hypofibrinolyse est-elle un facteru de risque de thrombose? = Defective fibrinolysis: risk factor of venous thrombosisJUHAN-VAGUE, I.La Revue du praticien (Paris). 1989, Vol 39, Num 26, pp 2337-2339, issn 0035-2640Article

Hypofibrinolysis and insulin-resistanceJUHAN-VAGUE, I; VAGUE, P.Diabète et métabolisme (Paris). 1991, Vol 17, Num 1BIS, pp 96-100, issn 0338-1684, 5 p.Conference Paper

Athérome et antithrombotiques = Atheroma and antithromboticsJUHAN-VAGUE, I.Archives des maladies du coeur et des vaisseaux. 1992, Vol 85, pp 171-173, issn 0003-9683, NS2Conference Paper

Interrelations between carbohydrates, lipids, and the hemostatic system in relation to the risk of thrombotic and cardiovascular diseaseJUHAN-VAGUE, I; VAGUE, P.American journal of obstetrics and gynecology. 1990, Vol 163, Num 1, pp 313-315, issn 0002-9378, 3 p., . 2Article

MEASUREMENT OF HUMAN TISSUE-TYPE PLASMINOGEN ACTIVATOR BY A TWO-SITE IMMUNORADIOMETRIC ASSAYRIJKEN DC; JUHAN VAGUE I; DECOCK F et al.1983; JOURNAL OF LABORATORY AND CLINICAL MEDICINE; ISSN 0022-2143; USA; DA. 1983; VOL. 101; NO 2; PP. 274-284; BIBL. 24 REF.Article

Principles for the design of rheological studies in diabetes mellitusVAGUE, P; JUHAN-VAGUE, I.Clinical hemorheology. 1987, Vol 7, Num 4, pp 637-647, issn 0271-5198Article

Dyslipidémies, hypolipidémiants et thrombose = Dyslipidaemia, lipid lowering drugs and thrombosisAMBROSI, P; JUHAN-VAGUE, I.Archives des maladies du coeur et des vaisseaux. 1995, Vol 88, Num 11, pp 1641-1645, issn 0003-9683Conference Paper

Diabète et fibrinolyse = Diabetes and fibrinolysisJUHAN-VAGUE, I; VAGUE, P.Revue française d'endocrinologie clinique, nutrition et métabolisme. 1990, Vol 31, Num 2, pp 121-129, issn 0048-8062, 9 p.Article

Les traitements fibrinolytiques = Fibrinolytic treatmentsBORY, M; JUHAN-VAGUE, I.Méditerranée médicale. 1985, Vol 13, Num 345, pp 35-43, issn 0302-9263Article

Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseasesMAVRI, A; ALESSI, M.-C; JUHAN-VAGUE, I et al.Journal of internal medicine. 2004, Vol 255, Num 4, pp 448-456, issn 0954-6820, 9 p.Article

Desmopressine et fibrinolyse = Desmopressin and fibrinolysisJUHAN-VAGUE, I.STV. Sang thrombose vaisseaux. 1995, Vol 7, Num AVR, pp 18-21, issn 0999-7385, NSConference Paper

Vieillissement de la paroi artérielle : endothélium, thrombose et fibrinolyse = Ageing of the artery wall. Endothelium, thrombosis and fibrinolysisJUHAN-VAGUE, I; ALESSI, M. C.Annales de cardiologie et d'angéiologie (Paris). 1991, Vol 40, Num 5, pp 243-247, issn 0003-3928, 5 p.Conference Paper

FUNCTIONAL AND ULTRASTRUCTURAL ALTERATIONS OF AUTOLOGOUS PLATELETS LABELED WITH ¹¹¹ IN-OXINEBERNARD P; BAZAN M; FOA C et al.1983; EUROPEAN JOURNAL OF NUCLEAR MEDICINE; ISSN 0340-6997; DEU; DA. 1983; VOL. 8; NO 4; PP. 172-178; BIBL. 31 REF.Article

The fibrinolytic system and obesityLIJNEN, H. R; JUHAN-VAGUE, I.Thrombosis and haemostasis. 2002, Vol 88, Num 5, issn 0340-6245, p. 882Article

Involvement of the hemostatic system in the insulin resistance syndrome : a study of 1500 patients with angina pectorisJUHAN-VAGUE, I; THOMPSON, S. G; JESPERSEN, J et al.Arteriosclerosis and thrombosis. 1993, Vol 13, Num 12, pp 1865-1873, issn 1049-8834Article

Increased plasma plasminogen activator inhibitor 1 levels. A possible link betwwen insulin resistance and atherothrombosisJUHAN-VAGUE, I; ALESSI, M. C; VAGUE, P et al.Diabetologia (Berlin). 1991, Vol 34, Num 7, pp 457-462, issn 0012-186XArticle

Endothélium, thrombose et fibrinolyse : Endothélium = Endothelium, thrombosis and fibrinolyses : EndotheliumALESSI, M.-C; JUHAN-VAGUE, I.La Revue du praticien (Paris). 1997, Vol 47, Num 20, pp 2227-2231, issn 0035-2640Article

Haemostatic parameters and vascular riskJUHAN-VAGUE, I.Atherosclerosis. 1996, Vol 124, pp S49-S55, issn 0021-9150, SUPConference Paper

COMPARISON OF THE EFFECTS OF ASPIRIN AND INDOMETHACIN ON AORTIC ATHEROGENESIS INDUCED IN RABBITSJOUVE R; JUHAN VAGUE I; AILLAUD MF et al.1982; ATHEROSCLEROSIS; ISSN 0021-9150; NLD; DA. 1982; VOL. 42; NO 2-3; PP. 319-321; BIBL. 14 REF.Article

Thrombolytiques et leur maniement : Médicaments antithrombotiques = Description and use of thrombolytic drugsALESSI, M.-C; JUHAN-VAGUE, I.La Revue du praticien (Paris). 1999, Vol 49, Num 15, pp 1654-1658, issn 0035-2640Article

ETUDE MORPHOLOGIQUE DE DIFFERENTS TYPES DE GREFFONS VEINEUX: ESSAI DE CORRELATION AVEC L'ACTIVITE FIBRINOLYTIQUE PARIETALECHOUX R; PAYAN MJ; JUHAN VAGUE I et al.1982; ANNALES DE PATHOLOGIE; ISSN 0242-6498; FRA; DA. 1982; VOL. 2; NO 4; PP. 293-300; ABS. ENG; BIBL. 27 REF.Article

TREATMENT OF VENOUS THROMBOSIS AND PULMONARY EMBOLISM BY STREPTOKINASESERRADIMIGNI A; BORY M; DJIANE P et al.1978; ANGIOLOGY; USA; DA. 1978; VOL. 29; NO 11; PP. 825-831; BIBL. 16 REF.Article

Regulation of fibrinolysis in the development of atherothrombosis : Role of adipose tissueJUHAN-VAGUE, I; ALESSI, M. C.Thrombosis and haemostasis. 1999, Vol 82, Num 2, pp 832-836, issn 0340-6245Article

Pathophysiology of fibrinolysisDECLERCK, P. J; JUHAN-VAGUE, I; FELEZ, J et al.Journal of internal medicine. 1994, Vol 236, Num 4, pp 425-432, issn 0954-6820Conference Paper

Plasminogen activator inhibitor 1 and atherothrombosisJUHAN-VAGUE, I; ALESSI, M. C.Thrombosis and haemostasis. 1993, Vol 70, Num 1, pp 138-143, issn 0340-6245Conference Paper